| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-04-01 | 2009-01-31 | N-Q | Thermo Fisher Scientific Inc | TMO | US | Instruments-Scientific | 78,150 | New Holding | 78,150 | 100 % | $2,686,797 | $3,638,664 | $951,867 | 35.42 % | $951,867 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Thermo Fisher Scientific Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Illumina Inc | ILMN | US | Medical-Biomedical/Gene | 130,880 | New Holding | 130,880 | 100 % | $4,669,798 | $3,508,893 | $-1,160,906 | -24.85 % | $-1,160,906 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Illumina Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Ipc The Hospitalist Co Inc | IPCM | US | Phys Practice Mgmnt | 160,800 | New Holding | 160,800 | 100 % | $3,011,784 | $5,123,088 | $2,111,304 | 70.10 % | $2,111,304 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Ipc The Hospitalist Co Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 160,300 | New Holding | 160,300 | 100 % | $5,921,482 | $7,005,110 | $1,083,628 | 18.29 % | $1,083,628 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Cephalon Inc | CEPH | US | Medical-Drugs | 50,750 | New Holding | 50,750 | 100 % | $3,494,645 | $3,025,208 | $-469,438 | -13.43 % | $-469,438 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Cephalon Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 184,100 | New Holding | 184,100 | 100 % | $4,593,295 | $6,430,613 | $1,837,318 | 40.00 % | $1,837,318 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 152,700 | New Holding | 152,700 | 100 % | $1,847,670 | $2,591,319 | $743,649 | 40.24 % | $743,649 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Allos Therapeutics Inc | ALTH | US | Therapeutics | 100,000 | New Holding | 100,000 | 100 % | $617,000 | $616,000 | $-1,000 | -0.16 % | $-1,000 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Allos Therapeutics Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Community Health Systems Inc | CYH | US | Medical-Hospitals | 194,250 | New Holding | 194,250 | 100 % | $2,902,095 | $5,979,015 | $3,076,920 | 106.02 % | $3,076,920 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Community Health Systems Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Baxter International Inc | BAX | US | Medical Products | 95,550 | New Holding | 95,550 | 100 % | $4,841,519 | $5,191,232 | $349,713 | 7.22 % | $349,713 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Baxter International Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Mylan Incpa | MYL | US | Medical-Generic Drugs | 663,600 | New Holding | 663,600 | 100 % | $8,892,240 | $11,646,180 | $2,753,940 | 30.97 % | $2,753,940 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Mylan Incpa |
| 2009-04-01 | 2009-01-31 | N-Q | Humana Inc | HUM | US | Medical-Hmo | 120,600 | New Holding | 120,600 | 100 % | $3,124,746 | $4,877,064 | $1,752,318 | 56.07 % | $1,752,318 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Humana Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Covidien Ltd | COV | BM | Medical Products | 170,650 | New Holding | 170,650 | 100 % | $5,655,341 | $7,790,173 | $2,134,832 | 37.74 % | $2,134,832 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Covidien Ltd |
| 2009-04-01 | 2009-01-31 | N-Q | Xenoport Inc | XNPT | US | Medical-Drugs | 115,400 | New Holding | 115,400 | 100 % | $2,109,512 | $1,886,790 | $-222,722 | -10.55 % | $-222,722 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Xenoport Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Insulet Corp | PODD | US | Patient Monitoring Equip | 262,250 | New Holding | 262,250 | 100 % | $1,111,940 | $3,238,788 | $2,126,848 | 191.27 % | $2,126,848 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Insulet Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 184,400 | New Holding | 184,400 | 100 % | $1,729,672 | $1,714,920 | $-14,752 | -0.85 % | $-14,752 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Seattle Genetics Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Ardea Biosciences Inc | RDEA | US | Medical-Drugs | 175,951 | New Holding | 175,951 | 100 % | $1,849,245 | $2,407,010 | $557,765 | 30.16 % | $557,765 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Ardea Biosciences Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Optimer Pharmaceuticals Inc | OPTR | US | Medical-Biomedical/Gene | 976,450 | New Holding | 976,450 | 100 % | $13,279,720 | $11,717,400 | $-1,562,320 | -11.76 % | $-1,562,320 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Optimer Pharmaceuticals Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Micrus Endovascular Corp | MEND | US | Medical Instruments | 135,597 | New Holding | 135,597 | 100 % | $809,514 | $1,757,337 | $947,823 | 117.08 % | $947,823 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Micrus Endovascular Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Abiomed Inc | ABMD | US | Medical Products | 82,500 | New Holding | 82,500 | 100 % | $408,375 | $671,550 | $263,175 | 64.44 % | $263,175 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Abiomed Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Bristol-Myers Squibb Co | BMY | BE | Medical-Drugs | 251,100 | New Holding | 251,100 | 100 % | $5,516,667 | $6,141,906 | $625,239 | 11.33 % | $625,239 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Bristol-Myers Squibb Co |
| 2009-04-01 | 2009-01-31 | N-Q | Masimo Corp | MASI | US | Patient Monitoring Equip | 96,450 | New Holding | 96,450 | 100 % | $2,825,985 | $2,591,612 | $-234,374 | -8.29 % | $-234,374 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Masimo Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 215,969 | New Holding | 215,969 | 100 % | $1,915,645 | $5,064,473 | $3,148,828 | 164.37 % | $3,148,828 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Par Pharmaceutical Cos Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Icon Plc | ICLR | US | Medical Labs And Testing Srv | 84,300 | New Holding | 84,300 | 100 % | $1,374,090 | $1,938,057 | $563,967 | 41.04 % | $563,967 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Icon Plc |
| 2009-04-01 | 2009-01-31 | N-Q | Parexel International Corp | PRXL | US | Research And Development | 251,774 | New Holding | 251,774 | 100 % | $2,517,740 | $3,159,764 | $642,024 | 25.50 % | $642,024 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Parexel International Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Meridian Bioscience Inc | VIVO | US | Diagnostic Kits | 87,950 | New Holding | 87,950 | 100 % | $1,591,895 | $1,833,758 | $241,863 | 15.19 % | $241,863 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Meridian Bioscience Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Teva Pharmaceutical Industries Ltd | TEVA | IL | Medical-Generic Drugs | 110,350 | New Holding | 110,350 | 100 % | $5,014,304 | $5,817,652 | $803,348 | 16.02 % | $803,348 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Teva Pharmaceutical Industries Ltd |
| 2009-04-01 | 2009-01-31 | N-Q | Perrigo Co | PRGO | IL | Medical-Generic Drugs | 89,250 | New Holding | 89,250 | 100 % | $2,208,045 | $3,508,418 | $1,300,373 | 58.89 % | $1,300,373 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Perrigo Co |
| 2009-04-01 | 2009-01-31 | N-Q | Cvscaremark Corp | CVS | US | Retail-Drug Store | 145,100 | New Holding | 145,100 | 100 % | $4,077,310 | $4,590,964 | $513,654 | 12.59 % | $513,654 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Cvscaremark Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Inverness Medical Innovations Inc | IMA | US | Diagnostic Kits | 263,450 | New Holding | 263,450 | 100 % | $7,052,557 | $10,959,520 | $3,906,964 | 55.39 % | $3,906,964 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Inverness Medical Innovations Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 128,500 | New Holding | 128,500 | 100 % | - | - | - | - % | | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Genentech Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 162,309 | New Holding | 162,309 | 100 % | $6,244,027 | $8,912,387 | $2,668,360 | 42.73 % | $2,668,360 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Celgene Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 78,050 | New Holding | 78,050 | 100 % | $4,468,363 | $3,906,403 | $-561,960 | -12.57 % | $-561,960 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Genzyme Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 45,000 | New Holding | 45,000 | 100 % | $2,028,150 | $1,062,000 | $-966,150 | -47.63 % | $-966,150 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Myriad Genetics Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Johnson And Johnson | JNJ | US | Medical Products | 109,400 | New Holding | 109,400 | 100 % | $5,802,576 | $6,816,714 | $1,014,138 | 17.47 % | $1,014,138 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Johnson And Johnson |
| 2009-04-01 | 2009-01-31 | N-Q | Actelion Ltd | ALIOF.OB | CH | Medical-Drugs | 29,100 | New Holding | 29,100 | 100 % | - | - | - | - % | | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Actelion Ltd |
| 2009-04-01 | 2009-01-31 | N-Q | Cubist Pharmaceuticals Inc | CBST | US | Medical-Drugs | 76,250 | New Holding | 76,250 | 100 % | $1,218,475 | $1,292,438 | $73,963 | 6.07 % | $73,963 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Cubist Pharmaceuticals Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Thoratec Corp | THOR | US | Medical Instruments | 121,350 | New Holding | 121,350 | 100 % | $3,116,268 | $3,526,431 | $410,163 | 13.16 % | $410,163 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Thoratec Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Shire Plc | SHPGY | DE | Medical-Drugs | 121,300 | New Holding | 121,300 | 100 % | $4,378,930 | $6,844,959 | $2,466,029 | 56.31 % | $2,466,029 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Shire Plc |
| 2009-04-01 | 2009-01-31 | N-Q | Amerigroup Corp | AGP | US | Medical-Hmo | 219,350 | New Holding | 219,350 | 100 % | $6,084,769 | $4,968,278 | $-1,116,492 | -18.34 % | $-1,116,492 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Amerigroup Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Unitedhealth Group Inc | UNH | US | Medical-Hmo | 105,250 | New Holding | 105,250 | 100 % | $2,176,570 | $3,005,940 | $829,370 | 38.10 % | $829,370 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Unitedhealth Group Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Aetna Inc | AET | US | Medical-Hmo | 100,650 | New Holding | 100,650 | 100 % | $2,428,685 | $2,858,460 | $429,776 | 17.69 % | $429,776 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Aetna Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Abbott Laboratories | ABT | US | Medical-Drugs | 152,150 | New Holding | 152,150 | 100 % | $7,105,405 | $8,161,326 | $1,055,921 | 14.86 % | $1,055,921 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Abbott Laboratories |
| 2009-04-01 | 2009-01-31 | N-Q | Boston Scientific Corp | BSX | US | Medical Instruments | 170,000 | New Holding | 170,000 | 100 % | $1,399,100 | $1,375,300 | $-23,800 | -1.70 % | $-23,800 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Boston Scientific Corp |
| 2009-04-01 | 2009-01-31 | N-Q | Wyeth | WYE | US | Medical-Drugs | 237,300 | New Holding | 237,300 | 100 % | $10,275,090 | - | - | - % | | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Wyeth |
| 2009-04-01 | 2009-01-31 | N-Q | St Jude Medical Inc | STJ | US | Medical Instruments | 230,650 | New Holding | 230,650 | 100 % | $8,319,546 | $7,915,908 | $-403,638 | -4.85 % | $-403,638 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of St Jude Medical Inc |
| 2009-04-01 | 2009-01-31 | N-Q | Pfizer Inc | PFE | US | Medical-Drugs | 505,000 | New Holding | 505,000 | 100 % | $7,064,950 | $9,271,800 | $2,206,850 | 31.23 % | $2,206,850 | | | | | | News Article | History of Alger Funds - Alger Health Sciences Fund Ownership Of Pfizer Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |